Filing Details

Accession Number:
0001209191-17-067233
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-26 17:06:28
Reporting Period:
2017-12-22
Accepted Time:
2017-12-26 17:06:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649989 Oncobiologics Inc. ONS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1527197 Kenneth Bahrt C/O Oncobiologics, Inc.
7 Clarke Drive
Cranbury NJ 08512
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-22 26,165 $1.13 54,820 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested restricted stock units ("RSUs"). This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.
  2. Includes 28,985 shares of the Issuer's common stock subject to RSUs that will vest 50% on each of the third and fourth year anniversaries of the 6/22/15 grant date, subject to continued service through such date. The vesting of RSUs reported on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on December 22, 2016 was accelerated such that 100% of the shares underling those RSUs vested on December 21, 2017.